Development of flow cytometry‐based assays to assess the ability of antibodies to bind to SARS‐CoV‐2‐infected and spike‐transfected cells and mediate NK cell degranulation
Dieter Mielke(Duke University), Guido Ferrari(Duke University), Shalini Jha(Duke University), Adam Zalaquett(Duke University), Georgia D. Tomaras(National Institutes of Health), Raquel A. Binder(Duke University), Nicole Rodgers(Duke University), Lawrence Corey(Fred Hutch Cancer Center), Brooke Dunn(Duke University), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Thomas H. Oguin, Gregory C. Gray(The University of Texas Medical Branch at Galveston), Gregory D. Sempowski(Duke University), Sherry Stanfield‐Oakley, Justin Pollara(Duke University), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Taylor Keyes(Duke University)
Cited by 10
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661